{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Leo Cui, General Partner, FoundersX Ventures \u201cFrom CRISPR to AI - Investing at the Frontier of Deep Tech\u201d","description":" Our guest for today\u2019s podcast is Leo Cui, who is a General Partner at FoundersX Ventures, where he invests in AI and deep-tech companies from Seed through Series B, with a particular focus on the intersection of data, analytics, biotechnology, and enterprise technology.  Based in Cambridge, Massachusetts, Leo brings a rare combination of scientific depth and venture investing experience. He earned his Ph.D. in Bioengineering from Harvard University and completed a postdoctoral fellowship in Professor Feng Zhang\u2019s lab at the Broad Institute of MIT and Harvard. His research in CRISPR and microfluidics led to multiple patents, peer-reviewed publications, and two spin-out companies focused on early cancer diagnostics and high-throughput drug discovery.  At FoundersX Ventures, Leo has backed companies including 1910 Genetics, Omniscope, Zafrens, Colabra, and Palamedrix. He also co-founded Nucleate, a student-led biotechnology entrepreneurship organization that expanded from Harvard to biohubs across the United States.  Leo has also built a loyal following on youtube for his deep research on all things AI.  His deep dive titled \u201cThe Entire Data Center Explained\u201d has amassed over 500,000 views and is a must view for AI investors.  Without further ado, here is our conversation with Leo Cui.  ","author_name":"AAAIM High ELI","author_url":"https:\/\/aaaim.org","html":"